Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1454 ARTÍCULOS , VIENDO DEL 1336 AL 1350

Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions

Biessels GJ, Strachan MW, Visseren FL, Kappelle LJ, Whitmer RA.

Lancet Diabetes Endocrinol. 2014 Mar;2(3):246-55. doi: 10.1016/S2213-8587(13)70088-3. Epub 2013 Oct 18.

Grouping of behavioural and psychological symptoms of dementia

van der Linde RM, Dening T, Matthews FE, Brayne C.

Int J Geriatr Psychiatry. 2014 Jun;29(6):562-8. doi: 10.1002/gps.4037. Epub 2013 Oct 16.

A commonly carried genetic variant in the delta opioid receptor gene, OPRD1, is associated with smaller regional brain volumes: replication in elderly and young populations

Roussotte FF, Jahanshad N, Hibar DP, Sowell ER, Kohannim O, Barysheva M, Hansell NK, McMahon KL, de Zubicaray GI, Montgomery GW, Martin NG, Wright MJ, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; ADNI.

Hum Brain Mapp. 2014 Apr;35(4):1226-36. doi: 10.1002/hbm.22247. Epub 2013 Feb 21.

Cholinergic markers in the cortex and hippocampus of some animal species and their correlation to Alzheimer's disease

Orta-Salazar E, Cuellar-Lemus CA, Díaz-Cintra S, Feria-Velasco AI.

Neurologia. 2014 Oct;29(8):497-503. doi: 10.1016/j.nrl.2012.10.007. Epub 2013 Feb 22.

Comparison between clinical diagnosis and CSF biomarkers of Alzheimer disease in elderly patients with late onset psychosis: Helsinki Old Age Psychosis Study (HOPS)

Seppälä TT, Louhija UM, Appelberg B, Herukka SK, Juva K.

Am J Geriatr Psychiatry. 2014 Sep;22(9):908-16. doi: 10.1016/j.jagp.2012.08.020. Epub 2013 Apr 15.

Biomarkers in amyloid-β immunotherapy trials in Alzheimer's disease

Blennow K, Hampel H, Zetterberg H.

Neuropsychopharmacology. 2014 Jan;39(1):189-201. doi: 10.1038/npp.2013.154. Epub 2013 Jun 25.

Atherosclerosis, biomarkers of atherosclerosis and Alzheimer's disease

Fiolaki A, Tsamis KI, Milionis HJ, Kyritsis AP, Kosmidou M, Giannopoulos S.

Int J Neurosci. 2014 Jan;124(1):1-11. doi: 10.3109/00207454.2013.821988. Epub 2013 Aug 6.

CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease

Lista S, Garaci FG, Ewers M, Teipel S, Zetterberg H, Blennow K, Hampel H.

Alzheimers Dement. 2014 May;10(3):381-92. doi: 10.1016/j.jalz.2013.04.506. Epub 2013 Jul 11.

The future of blood-based biomarkers for Alzheimer's disease

Henriksen K, O'Bryant SE, Hampel H, Trojanowski JQ, Montine TJ, Jeromin A, Blennow K, Lönneborg A, Wyss-Coray T, Soares H, Bazenet C, Sjögren M, Hu W, Lovestone S, Karsdal MA, Weiner MW; Blood-Based Biomarker Interest Group.

Alzheimers Dement. 2014 Jan;10(1):115-31. doi: 10.1016/j.jalz.2013.01.013. Epub 2013 Jul 11.

Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum

Donovan NJ, Wadsworth LP, Lorius N, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Marshall GA; Alzheimer Disease Neuroimaging Initiative.

Am J Geriatr Psychiatry. 2014 Nov;22(11):1168-79. doi: 10.1016/j.jagp.2013.03.006. Epub 2013 Jul 24.

Reduced frequency of T lymphocytes expressing CTLA-4 in frontotemporal dementia compared to Alzheimer's disease

Santos RR, Torres KC, Lima GS, Fiamoncini CM, Mapa FC, Pereira PA, Rezende VB, Martins LC, Bicalho MA, Moraes EN, Reis HJ, Teixeira AL, Romano-Silva MA.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:1-5. doi: 10.1016/j.pnpbp.2013.06.019. Epub 2013 Jul 25.

Neuroinflammation in Alzheimer's disease: an understanding of physiology and pathology

Obulesu M, Jhansilakshmi M.

Int J Neurosci. 2014 Apr;124(4):227-35. doi: 10.3109/00207454.2013.831852. Epub 2013 Sep 12.

Simulating effects of biomarker enrichment on Alzheimer's disease prevention trials: conceptual framework and example

Leoutsakos JM, Bartlett AL, Forrester SN, Lyketsos CG.

Alzheimers Dement. 2014 Mar;10(2):152-61. doi: 10.1016/j.jalz.2013.05.1776. Epub 2013 Aug 15.

A comparison of early diagnostic utility of Alzheimer disease biomarkers in brain magnetic resonance and cerebrospinal fluid

Monge Argilés JA, Blanco Cantó MA, Leiva Salinas C, Flors L, Muñoz Ruiz C, Sánchez Payá J, Gasparini Berenguer R, Leiva Santana C.

Neurologia. 2014 Sep;29(7):397-401. doi: 10.1016/j.nrl.2013.06.002. Epub 2013 Aug 20.

Comparing predictors of conversion to Alzheimer's disease using the disease state index

Muñoz-Ruiz MÁ, Hall A, Mattila J, Koikkalainen J, Herukka SK, Vanninen R, Liu Y, Lötjönen J, Soininen H; Alzheimer’s Disease Neuroimaging Initiative.

Neurodegener Dis. 2014;13(2-3):200-2. doi: 10.1159/000354074. Epub 2013 Aug 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias